MARINUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.47 USD | +4.26% |
|
+2.08% | -86.48% |
| 04-17 | Truist Adjusts Marinus Pharmaceuticals' PT to $10 From $25, Keeps Buy Rating | MT |
| 04-16 | Baird Downgrades Marinus Pharmaceuticals to Neutral, Price Target at $2 | MT |
Chart calendar Marinus Pharmaceuticals, Inc.
67.wSLiqm4lyr_TtY39udR4vMZOKoX2ByK76K5Q2sd9pnc.l0_WkjRk_9iG8bmQ1p0N6qMGc9afUkOWoc8KqpQQ5AGIEYnmWEyy3L3j_g~0e4a721ac5415d74d65b32b2b34395e5
Upcoming events on Marinus Pharmaceuticals, Inc.
Past events on Marinus Pharmaceuticals, Inc.
| 11/03/2024 20:00 | Leerink Partners Global Biopharma Conference |
| 06/03/2024 15:30 | TD Cowen Health Care Conference |
| 05/03/2024 21:30 | Q4 2023 Earnings Call |
| 05/03/2024 12:01 | Q4 2023 Earnings Release |
| 04/12/2023 17:00 | American Epilepsy Society Meeting - R. Rajaraman |
| 04/12/2023 17:00 | American Epilepsy Society Meeting - M. Gasior |
| 04/12/2023 17:00 | American Epilepsy Society Meeting - P. Anantharam |
| 04/12/2023 16:00 | American Epilepsy Society Meeting |
| 03/12/2023 17:00 | American Epilepsy Society Meeting - M. Barra |
| 03/12/2023 17:00 | American Epilepsy Society Meeting - J. Flatt |
| 03/12/2023 17:00 | American Epilepsy Society Meeting - E. Pestana-Knight |
| 03/12/2023 17:00 | American Epilepsy Society Meeting - J. Hulihan |
| 28/11/2023 17:55 | Evercore ISI HealthCONx Conference |
| 07/11/2023 13:30 | Q3 2023 Earnings Call |
| 07/11/2023 12:01 | Q3 2023 Earnings Release |
| 28/09/2023 15:55 | Cantor Global Healthcare Conference |
| 19/09/2023 14:00 | Investor & Analyst Meeting |
| 10/08/2023 13:30 | Q2 2023 Earnings Call |
| 10/08/2023 12:01 | Q2 2023 Earnings Release |
| 10/07/2023 | SVB Securities Therapeutics Forum |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 1,72 1,39 23.96% | 15,3 17,2 -10.68% | 25,5 27,7 -8.07% | 31,0 31,9 -2.94% | 41,1 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -54,4 -52,5 -3.65% | -67,9 -66,4 -2.29% | -95,5 -96,5 1.13% | -113 -114 1.22% | -131 -129 -1.6% | -125 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -54,1 -52,2 -3.64% | -67,5 -68,9 2.07% | -98,8 -97,9 -0.88% | -16,4 -7,92 -107.52% | -143 -136 -4.77% | -136 |
|
Net income Million USD | Released Forecast Spread | -54,1 -52,2 -3.64% | -76,4 -72,2 -5.79% | -98,8 -98,3 -0.52% | -19,8 -12,8 -54.95% | -141 -135 -4.66% | -133 |
|
EPS USD | Released Forecast Spread | -3,96 -3,75 -5.64% | -2,80 -2,45 -14.15% | -2,69 -2,68 -0.3% | -0,51 -0,33 -54.08% | -2,63 -2,53 -4% | -2,23 |
| Announcement Date | 16/03/20 | 09/03/21 | 21/03/22 | 09/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,52 3,37 -54.85% | 14,2 2,28 523.09% | 1,79 2,32 -22.68% | 2,34 25,8 -90.92% | 7,16 9,15 -21.71% | 10,4 4,91 111.52% | 6,08 5,74 6.02% | 7,34 6,31 16.21% | 7,19 8,14 -11.66% | 9,13 | 9,59 | 10,5 | 11,9 | 11,2 |
|
EBIT Million USD | Released Forecast Spread | -27,1 -26,7 -1.51% | -16,7 -30,2 44.66% | -36,8 -32,8 -12.06% | -30,1 -2,43 -1140.94% | -29,2 -31,1 6.1% | -33,0 -34,7 4.98% | -31,4 -35,9 12.38% | -31,6 -33,6 5.87% | -35,4 -33,4 -6.2% | -36,2 | -32,8 | -29,2 | -26,8 | -26,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,3 -27,4 -3.37% | -19,4 -30,8 37.11% | -39,4 -21,6 -82.9% | 75,0 32,3 132.6% | -32,7 -24,3 -34.51% | -34,7 -37,4 7.09% | -33,5 -37,7 11.18% | -33,0 -35,3 6.69% | -41,8 -35,3 -18.35% | -37,5 | -35,7 | -32,3 | -30,1 | -28,7 |
|
Net income Million USD | Released Forecast Spread | -28,3 -27,8 -2% | -19,4 -31,2 37.97% | -39,4 -23,4 -68.61% | 71,6 12,7 465.87% | -34,3 -26,8 -27.93% | -34,7 -37,0 6.23% | -31,9 -37,7 15.34% | -33,0 -35,2 6.44% | -41,8 -35,3 -18.18% | -36,9 | -35,4 | -31,2 | -29,1 | -27,4 |
|
EPS USD | Released Forecast Spread | -0,77 -0,76 -1.18% | -0,52 -0,85 38.82% | -1,06 -0,69 -54.74% | 1,89 0,40 376.47% | -0,76 -0,60 -25.83% | -0,67 -0,80 15.83% | -0,61 -0,71 14.57% | -0,61 -0,67 8.82% | -0,74 -0,62 -18.72% | -0,66 | -0,60 | -0,55 | -0,45 | -0,29 |
| Announcement Date | 21/03/22 | 12/05/22 | 11/08/22 | 07/11/22 | 09/03/23 | 11/05/23 | 10/08/23 | 07/11/23 | 05/03/24 | - | - | - | - | - |
More events
Past sector events for Marinus Pharmaceuticals, Inc.
| Today 12:30 | ORGANON & CO.: Q1 2024 Earnings Release |
| Today 06:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 01/05/2024 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
| 01/05/2024 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 01/05/2024 07:00 | GSK PLC: Q1 2024 Earnings Release |
| 30/04/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRNS Stock
- Calendar Marinus Pharmaceuticals, Inc.
